tetano
Editor, Senior Moderator
Value Health. 2013 May;16(3):A89. doi: 10.1016/j.jval.2013.03.415. Epub 2013 May 3.
Potential benefits analysis of quadrivalent influenza vaccine (qiv) on influenza disease burden in the United kingdom, year by year analysis (2000-2010).
Meier G, Van Bellinghen LA, Van Vlaenderen I.
Source
GlaxoSmithKline Vaccines, King of Prussia, PA, USA.
PMID:
23694614
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/23694614
Potential benefits analysis of quadrivalent influenza vaccine (qiv) on influenza disease burden in the United kingdom, year by year analysis (2000-2010).
Meier G, Van Bellinghen LA, Van Vlaenderen I.
Source
GlaxoSmithKline Vaccines, King of Prussia, PA, USA.
PMID:
23694614
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/23694614